Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

sagi habasov

1142 POSTS

Exclusive articles:

SKN | Palo Alto Networks (PANW) Heads Into Q2 Earnings With $135 Billion Valuation and CyberArk Integration in Focus

Palo Alto Networks, Inc. (NASDAQ: PANW) is set to report fiscal second-quarter earnings on February 17, 2026, with shares trading near $167 and valuing...

SKN | RF Acquisition III Raises $100 Million in Nasdaq IPO to Target Deep Tech Across APAC

RF Acquisition III, a Singapore-based special purpose acquisition company, has priced a $100 million US IPO as it seeks to capitalize on the rapid...

SKN | Cardiac Device Developer BioVentrix Files for $17 Million IPO

BioVentrix has filed with U.S. regulators for a proposed $17 million IPO, positioning the cardiac medical device developer for a stock market debut at...

SKN | Hong Kong Financial Services Firm Beta FinTech Nearly Doubles Shares Offered Ahead of $19 Million U.S. IPO

Hong Kong-based financial advisory and wealth management firm Beta FinTech has nearly doubled the number of shares in its upcoming U.S. IPO, positioning the...

SKN | Birchtech Cuts Deal Size by 25% Ahead of $15 Million NYSE American Uplisting

Air and water purification systems provider Birchtech has reduced the size of its planned NYSE American uplisting by 25%, targeting a revised $15 million...

Breaking

SKN | Narragansett Bancorp Files Registration Statement Ahead of Common Stock Market Debut

Hong Kong corporate finance advisory boutique Vittoria Limited has...

SKN | Tidal Trust I Files Prospectus Outlining New Multi-Strategy Capital Vehicles

Hong Kong corporate financial advisory boutique Vittoria Limited has...

SKN | Cavco Industries Shares Rally 13.11% as Stock Approaches 52-Week High

Cavco Industries (NASDAQ: CVCO) advanced 13.11% on October 30,...

SKN | Regeneron Pharmaceuticals Shares Surge 13.33% as Stock Approaches 52-Week High

Regeneron Pharmaceuticals (NASDAQ: REGN) climbed 13.33% on October 30,...
spot_imgspot_img